We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$250M
AUM Growth
+$44.6M
Cap. Flow
+$75.5M
Cap. Flow %
30.26%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$71.3M
2
HSTO
Histogen Inc. Common Stock
HSTO
+$4.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 47.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$124M 49.5%
3,887,502
– –
RYTM icon
2
Rhythm Pharmaceuticals
RYTM
$7.28B
$78.4M 31.4%
+2,696,392
New +$71.3M
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$2.01B
$19M 7.61%
2,168,691
– –
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
$9.75M 3.91%
5,736,296
– –
HSTO
5
DELISTED
Histogen Inc. Common Stock
HSTO
$9.71M 3.89%
10,506
+4,546
+76% +$4.2M
ELGX
6
DELISTED
Endologix Inc
ELGX
$6M 2.4%
112,145
– –
TARA icon
7
Protara Therapeutics
TARA
$229M
$1.87M 0.75%
24,585
– –
PETX
8
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.31M 0.53%
250,000
– –
ALT icon
9
Altimmune
ALT
$554M
$14K 0.01%
233
– –

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, MPM Asset Management held 9 positions worth $250M, up 22% from $205M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management deployed $75.5M of net new capital in Q4 2017, opening 1 new position and adding to 1 existing holding. Its largest new stake was Rhythm Pharmaceuticals: 2,696,392 shares worth $78.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 24% a quarter earlier.

  • MPM Asset Management's largest Q4 2017 buy was Rhythm Pharmaceuticals: 2,696,392 shares worth $78.4M.
  • MPM Asset Management added most to Histogen Inc. Common Stock in Q4 2017, an estimated $4.2M increase.
  • MPM Asset Management's ten largest holdings make up 100% of its $250M portfolio in Q4 2017.
  • MPM Asset Management opened 1 new position and closed 0 in Q4 2017.
  • MPM Asset Management's portfolio value rose 22% quarter-over-quarter to $250M.

Based on MPM Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.